申请人:Pfizer Limited
公开号:EP0157626A2
公开(公告)日:1985-10-09
Compounds of the formula:
and their pharmaceutically acceptable acid addition salts, wherein,
R is H, Cl, Br, -CH(OH).Ph or -CH(OH).cyclohexyl;
each Ph is independently optionally substituted phenyl;
n is an integer of from 2 to 7;
and either R1 and R2 are each independently H or C1-C4 alkyl, or R1 and R2 taken together with the nitrogen atom to which they are attached represent a group of the formula:
where R3 is H or C1-C4 alkyl.
The compounds are anti-diarrhoeal agents.
式中,R 是 H、Cl、Br、-CH(OH).Ph 或 -CH(OH).环己基;每个 Ph 独立地是任选取代的苯基;n 是 2 至 7 的整数;R1 和 R2 独立地各自是 H 或 C1-C4 烷基,或 R1 和 R2 与它们所连接的氮原子一起代表式中的一个基团: 其中 R3 是 H 或 C1-C4 烷基。 这些化合物是止泻剂。